UPMC Cancer Centers works in tandem with the University of Pittsburgh Cancer Institute (UPCI), which comprises the academic and research activities for cancer at the University of Pittsburgh and the University of Pittsburgh Medical Center, to offer patients the latest advances in cancer prevention, detection, diagnosis and treatment.
The Brain Cancer Program's particular areas of research focus on radiation sensitivity, immunobiology and immunotherapy and resistance to drug therapy. We also have an interest in biologic therapies that might prevent progression of low-grade brain cancers that often progress to more malignant forms.
Patients seen at the Brain Cancer Program have access to many innovative clinical trials, including National Cancer Institute cooperative group studies, industry-sponsored trials and unique, early phase protocols based on research conducted at UPCI.
For more detailed information on the Program's research activities, including current research, accomplishments and future directions, visit the Brain Cancer Program at the University of Pittsburgh Cancer Institute.
